Search Results

There are 30575 results for: content related to: Cost Effectiveness of Duloxetine for Osteoarthritis: A Quebec Societal Perspective

  1. You have free access to this content
    Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

    Intervention Review

    The Cochrane Library

    Michael PT Lunn, Richard AC Hughes and Philip J Wiffen

    Published Online : 3 JAN 2014, DOI: 10.1002/14651858.CD007115.pub3

  2. Duloxetine versus other anti-depressive agents for depression

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Markus Koesters, Toshi A Furukawa, Michela Nosè, Marianna Purgato, Ichiro M Omori, Carlotta Trespidi and Corrado Barbui

    Published Online : 17 OCT 2012, DOI: 10.1002/14651858.CD006533.pub2

  3. You have free access to this content
    Clinical Characteristics and Medication Uses Among Fibromyalgia Patients Newly Prescribed Amitriptyline, Duloxetine, Gabapentin, or Pregabalin

    Arthritis Care & Research

    Volume 65, Issue 11, November 2013, Pages: 1813–1819, Seoyoung C. Kim, Joan E. Landon and Daniel H. Solomon

    Version of Record online : 28 OCT 2013, DOI: 10.1002/acr.22071

  4. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults

    Intervention Review

    The Cochrane Library

    Paramananthan Mariappan, Ammar A Alhasso, Adrian Grant and James MO N'Dow

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD004742.pub2

  5. Potential Drug–Drug and Drug–Condition Interactions among Fibromyalgia Patients Initiating Pregabalin or Duloxetine: Prevalence and Health Care Expenditure Impact

    Pain Medicine

    Volume 15, Issue 8, August 2014, Pages: 1282–1293, Stephen S. Johnston, Margarita Udall, Joseph C. Cappelleri, Barbara H. Johnson, George Shrady, Bong-Chul Chu and Stuart L. Silverman

    Version of Record online : 8 JAN 2014, DOI: 10.1111/pme.12330

  6. Health Care Costs in Patients with Painful Diabetic Peripheral Neuropathy Prescribed Pregabalin or Duloxetine

    Pain Practice

    Volume 12, Issue 3, March 2012, Pages: 209–218, James P. Burke, Robert J. Sanchez, Ashish V. Joshi, Joseph C. Cappelleri, Mahesh Kulakodlu and Rachel Halpern

    Version of Record online : 16 JUN 2011, DOI: 10.1111/j.1533-2500.2011.00478.x

  7. You have free access to this content
    Safety and tolerability of duloxetine in women with stress urinary incontinence

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 113, Issue s1, May 2006, Pages: 22–26, M Oelke, J-PWR Roovers and MC Michel

    Version of Record online : 9 MAR 2006, DOI: 10.1111/j.1471-0528.2006.00880.x

  8. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain

    International Journal of Clinical Practice

    Volume 68, Issue 9, September 2014, Pages: 1130–1140, G. Irving, R. J. Tanenberg, J. Raskin, R. C. Risser and S. Malcolm

    Version of Record online : 18 MAY 2014, DOI: 10.1111/ijcp.12452

  9. You have free access to this content

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A221–A237,

    Version of Record online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_1.x

    Corrected by:


    Vol. 13, Issue 2, 335, Version of Record online: 17 DEC 2009

  10. Duloxetine in treatment of anxiety symptoms associated with depression

    Depression and Anxiety

    Volume 18, Issue 2, September 2003, Pages: 53–61, David L. Dunner, David J. Goldstein, Craig Mallinckrodt, Yili Lu and Michael J. Detke

    Version of Record online : 2 SEP 2003, DOI: 10.1002/da.10122

  11. Duloxetine Use in Employees with Low Back Pain: Treatment Patterns and Direct and Indirect Costs

    Pain Medicine

    Volume 15, Issue 6, June 2014, Pages: 1015–1026, Jasmina I. Ivanova, Howard G. Birnbaum, Evan Kantor, Matt Schiller and Ralph W. Swindle

    Version of Record online : 15 FEB 2014, DOI: 10.1111/pme.12362

  12. You have free access to this content
    Duloxetine Pharmacology: Profile of a Dual Monoamine Modulator

    CNS Drug Reviews

    Volume 8, Issue 4, December 2002, Pages: 361–376, Kelly D. Karpa, Jane E. Cavanaugh and Joan M. Lakoski

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2002.tb00234.x

  13. You have free access to this content
    A Review of Duloxetine 60 mg Once-Daily Dosing for the Management of Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain Due to Chronic Osteoarthritis Pain and Low Back Pain

    Pain Practice

    Volume 13, Issue 3, March 2013, Pages: 239–252, Joseph V. Pergolizzi Jr, Robert B. Raffa, Robert Taylor Jr, Gabriel Rodriguez, Srinivas Nalamachu and Paul Langley

    Version of Record online : 21 JUN 2012, DOI: 10.1111/j.1533-2500.2012.00578.x

  14. Duloxetine: A Dual Serotonin-Norepinephrine Reuptake Inhibitor for Treatment of Major Depressive Disorder

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 3, March 2005, Pages: 396–410, Dr. Jennifer L. Kirwin and Dr. Jessica L. Gören

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.25.3.396.61600

  15. You have full text access to this OnlineOpen article
    Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo

    International Journal of Clinical Practice

    Volume 69, Issue 9, September 2015, Pages: 957–966, Y. Gao, X. Guo, P. Han, Q. Li, G. Yang, S. Qu, L. Yue, C.-N. Wang, V. Skljarevski, H. Dueñas, J. Raskin and L. Gu

    Version of Record online : 4 MAY 2015, DOI: 10.1111/ijcp.12641

  16. Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of Warfarin at Steady State in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 49, Issue 12, December 2009, Pages: 1456–1466, Dr Jill Chappell, Dr Jingsong He, Dr Mary Pat Knadler, Dr Malcolm Mitchell, Dr Douglas Lee and Dr Evelyn Lobo

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009344335

  17. Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study

    International Journal of Clinical Practice

    Volume 64, Issue 6, May 2010, Pages: 719–726, K. Kelin, M. Berk, M. Spann, D. Sagman, J. Raskin, D. Walker and D. Perahia

    Version of Record online : 23 MAR 2010, DOI: 10.1111/j.1742-1241.2010.02374.x

  18. Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials

    Pain Medicine

    Volume 16, Issue 7, July 2015, Pages: 1373–1385, Zhao Yu Wang, Sheng Ying Shi, Shu Jie Li, Feng Chen, Huang Chen, Hai Zhen Lin and Jing Ming Lin

    Version of Record online : 5 JUN 2015, DOI: 10.1111/pme.12800

  19. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

    Human Psychopharmacology: Clinical and Experimental

    Volume 20, Issue 5, July 2005, Pages: 327–341, James I. Hudson, Madelaine M. Wohlreich, Daniel K. Kajdasz, Craig H. Mallinckrodt, John G. Watkin and Oleg V. Martynov

    Version of Record online : 24 MAY 2005, DOI: 10.1002/hup.696

  20. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome

    Intervention Review

    The Cochrane Library

    Winfried Häuser, Gerard Urrútia, Sera Tort, Nurcan Üçeyler and Brian Walitt

    Published Online : 31 JAN 2013, DOI: 10.1002/14651858.CD010292